Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Puma Biotechnology (PBYI) R&D In Process (2022)

Puma Biotechnology's R&D In Process history spans 1 years, with the latest figure at $7.0 million for Q3 2022.

  • For Q3 2022, R&D In Process changed N/A year-over-year to $7.0 million; the TTM value through Dec 2023 reached $7.0 million, changed N/A, while the annual FY2022 figure was $7.0 million, N/A changed from the prior year.
  • R&D In Process reached $7.0 million in Q3 2022 per PBYI's latest filing.
  • In the past five years, R&D In Process ranged from a high of $7.0 million in Q3 2022 to a low of $7.0 million in Q3 2022.